222 related articles for article (PubMed ID: 37478770)
1. Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer.
Choudhury H; Pandey M; Saravanan V; Mun ATY; Bhattamisra SK; Parikh A; Garg S; Gorain B
Biomater Adv; 2023 Oct; 153():213556. PubMed ID: 37478770
[TBL] [Abstract][Full Text] [Related]
2. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanocarriers: A promising tool for early diagnosis and efficient treatment of colorectal cancer.
Haider M; Zaki KZ; El Hamshary MR; Hussain Z; Orive G; Ibrahim HO
J Adv Res; 2022 Jul; 39():237-255. PubMed ID: 35777911
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
[TBL] [Abstract][Full Text] [Related]
6. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
7. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
8. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
[TBL] [Abstract][Full Text] [Related]
9. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation.
Kaur J; Gulati M; Jha NK; Disouza J; Patravale V; Dua K; Singh SK
Drug Discov Today; 2022 May; 27(5):1495-1512. PubMed ID: 35158056
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.
Li Y; Xin J; Sun Y; Han T; Zhang H; An F
Cancer Biol Med; 2020 May; 17(2):307-327. PubMed ID: 32587771
[TBL] [Abstract][Full Text] [Related]
12. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.
Alotaibi BS; Buabeid M; Ibrahim NA; Kharaba ZJ; Ijaz M; Noreen S; Murtaza G
Int J Nanomedicine; 2021; 16():7517-7533. PubMed ID: 34795481
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges.
Di Filippo LD; de Paula MC; Duarte JL; de Paula GA; Frigieri I; Chorilli M
Expert Opin Drug Deliv; 2023 Jun; 20(6):831-849. PubMed ID: 37259517
[TBL] [Abstract][Full Text] [Related]
16. Folic-Acid-Conjugated Thermoresponsive Polymeric Particles for Targeted Delivery of 5-Fluorouracil to CRC Cells.
Milewska S; Siemiaszko G; Wilczewska AZ; Misztalewska-Turkowicz I; Markiewicz KH; Szymczuk D; Sawicka D; Car H; Lazny R; Niemirowicz-Laskowska K
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674883
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
[TBL] [Abstract][Full Text] [Related]
18. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
19. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
20. Oral nanoparticulate drug delivery systems for the treatment of intestinal bowel disease and colorectal cancer.
Laffleur F; Mayer AH
Expert Opin Drug Deliv; 2023; 20(11):1595-1607. PubMed ID: 38044874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
